NCT00440141 - Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005% | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions

GlaucomaOcular Hypertension

Interventions

DRUG

latanoprost 0.005% eye drops and brimonidine 0.1% eye drops

latanoprost 0.005%, 1 drop nightly for 3 months and brimonidine 0.1% three-times daily for 3 months

DRUG

latanoprost 0.005% eye drops and brinzolamide 1.0% eye drops

latanoprost 0.005% 1 drop nightly for 3 months AND brinzolamide 1.0% 1% three-times daily for 3 months

Trial Locations (1)

Atlanta